NCT01263535

Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients

Circadian Continuous Intraocular Pressure Monitoring With SENSIMED Triggerfish® Ocular Telemetry Sensor in Patients on Tafluprost Treatment

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Sensimed AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial is designed to investigate the performance of SENSIMED Triggerfish® during 24-hour continuous IOP fluctuation monitoring, defined as the number of valid recording intervals over the 24-hour period. The investigation will recruit male and female patients older than 18 years and diagnosed with glaucoma and treated with tafluprost in both eyes. 20 subjects will be enrolled in the study. Patients will be considered enrolled in the study upon signature of informed consent. A screening visit and one 24-hour IOP fluctuation monitoring session during a 36-hour hospitalisation, are planned for each patient.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DEVICE	SENSIMED Triggerfish	Contact lens-based device for the continuous recording of IOP fluctuations, with a portable recording system

Timeline

• Start date: 2010-09-01
• Primary completion: 2012-04-01
• Completion: 2012-05-01
• First posted: 2010-12-20
• Last updated: 2012-08-28

Locations

1 site across 1 country: Switzerland